Nantahala's 9.99% passive stake is just below the 10% threshold that triggers additional disclosure and trading restrictions. The inclusion of convertible securities suggests potential for further economic exposure. Monitor for any amendment or conversion to SC 13D if Nantahala's intent changes.
AEON drugs
AEON drug pipeline →Price Chart
How similar events traded
Executive Summary
Nantahala Capital Management, LLC disclosed a 9.99% passive beneficial ownership stake in AEON Biopharma as of September 30, 2026, holding 5,048,027 shares (including 648,027 shares from convertible securities). This is a new filing by Nantahala; the prior SC 13G was filed by Timothy P. Lynch, a different reporting person.
Key Financial Metrics
Key Facts
- Nantahala Capital Management, LLC filed a Schedule 13G disclosing beneficial ownership of 5,048,027 shares of AEON Biopharma Class A common stock.
- The stake represents 9.99% of shares outstanding as of September 30, 2026.
- The 5,048,027 shares include 648,027 shares that may be acquired within 60 days through exercise of convertible securities.
- The filing certifies passive intent under Rule 13d-1(b) with no purpose of changing or influencing control.
- Wilmot B. Harkey and Daniel Mack, as managing members of Nantahala, are also each reported as beneficial owners of the same 9.99% stake.
- The prior SC 13G (filed August 21, 2026) was by Timothy P. Lynch, not Nantahala, so this is a new reporting person.
Financial Impact
9.99% stake in a company with a $12M market cap implies a position value of approximately $1.2M at the snapshot price.
Risk Factors
- A 9.99% stake near the 10% threshold may invite regulatory scrutiny or signal potential future activism.
- The company's small $12M market cap makes this a concentrated position, increasing volatility risk from any change in Nantahala's holdings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001104659-26-127174 |
| Document: 0001104659-26-127174-index.html | 0001104659-26-127174 |
| Document: 0001104659-26-127174.txt | 0001104659-26-127174 |
Track record
22 reports on AEON
8 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +44.50% at T+60 after the Jul 9, 2026 report. 9 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $0.1600 Now $0.1410 −11.87% settles Nov 24
- Nov 16, 2026today Press Release Neutral 5/10 Entry $0.1410 Now $0.1410 +0.00% settles Nov 24
- Nov 13, 20263d ago SC 13G Neutral 4/10 Viewing Entry $0.1610 Now $0.1410 −12.42% settles Nov 23
- Nov 10, 20266d ago SC 13D/A Neutral 3/10 Entry $0.1793 Now $0.1410 −21.36% settles Nov 17
- Nov 9, 20267d ago Press Release Neutral 4/10 Entry $0.1818 to $0.1407 Now $0.1410 −22.44% ▼ −22.61% −20.91% vs SPY
- Nov 3, 202613d ago 8-K Neutral 4/10 Entry $0.2122 to $0.1793 Now $0.1410 −33.55% ▼ −15.50% −14.92% vs SPY
- Oct 26, 202621d ago DEF 14A Neutral 3/10 Entry $0.2483 to $0.2122 Now $0.1410 −43.21% ▼ −14.54% −12.55% vs SPY
- Oct 23, 202624d ago 8-K Neutral 4/10 Entry $0.2400 to $0.2740 Now $0.1410 −41.25% ▲ +14.17% +15.43% vs SPY
- Sep 30, 20266w ago 8-K Bullish 7/10 Entry $0.3000 to $0.3110 Now $0.1410 −53.00% ▲ +3.67% +1.75% vs SPY
- Aug 21, 202612w ago 3 Neutral Not scored Entry $0.1974 to $0.2959 Now $0.1410 −28.57% ▲ +49.90% +49.43% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers